4.8 Article

NHC-Catalyzed/Titanium(IV)-Mediated Highly Diastereo- and Enantioselective Dimerization of Enals

期刊

ORGANIC LETTERS
卷 13, 期 5, 页码 1068-1071

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ol103112v

关键词

-

资金

  1. NIH [RO1-NIGMS]
  2. Amgen
  3. AstraZeneca
  4. GlaxoSmithKline
  5. GAANN
  6. FQRNT (Fonds Quebecois de la Recherche sur la Nature et les Technologies)
  7. U.S. Department of Energy [DE-AC02-06CH11357]
  8. Michigan Economic Development Corp. [085P1000817]

向作者/读者索取更多资源

An NHC-catalyzed, diastereo- and enantioselective dimerization of enals has been developed. The use of Ti(Oi-Pr)(4) is a key element for the reactivity and selectivity of this process. The cyclopentenes are obtained with high levels of diastereo- and enantioselectivity and their synthetic utility is demonstrated by functionalization of the product alkene.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据